Research Progress on Risk Factors of Brain Metastasis in Non-small Cell Lung Cancer

Chinese Journal of Lung Cancer

Shuang SUN¹  Zhouguang HUI¹  Yu MEN¹ 

[1] Department of Radiation Oncology, National Cancer Center/National Clinical Research 
Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100021, China;

关键词: lung neoplasms;    brain metastasis;    prophylactic cranial irradiation;   

DOI  :  10.3779/j.issn.1009-3419.2022.101.08

来源: DOAJ

【 摘 要 】

Brain metastasis of non-small cell lung cancer (NSCLC) is a common treatment failure mode, and the median survival time of NSCLC patients with brain metastasis is only 1 mon-2 mon. Prophylactic cranial irradiation (PCI) can delay the occurrence of brain metastasis, but the survival benefits of NSCLC patients are still controversial. It is particularly important to identify the patients who are most likely to benefit from PCI. This article reviews the high risk factors of brain metastasis in NSCLC.

【 授权许可】

Unknown